Model
Edge
Alnylam Pharmaceuticals, Inc.
0001886431
Filing Type
144
Filing Date
1/12/2026
Updated
1/13/26, 2:32 PM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities